ClinConnect ClinConnect Logo
Search / Trial NCT06555094

Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App

Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Aug 12, 2024

Trial Information

Current as of November 14, 2025

Recruiting

Keywords

Suicide Attempt Suicide Suicidal Ideation Unified Protocol Ecological Momentary Intervention Mhealth

ClinConnect Summary

This clinical trial is studying a new way to help people who have thoughts of suicide or have recently attempted suicide. The goal is to see if using a mobile app along with brief therapy can help individuals learn skills to manage their negative emotions and reduce emotional distress and suicidal thoughts. Participants will learn three specific skills to cope with their feelings and will receive reminders on their smartphones to practice these skills.

To be eligible for this study, you must be an adult (18 years or older) who has either made a recent suicide attempt or is currently experiencing suicidal thoughts. You should also be able to speak and write in English and have a smartphone with internet access. If you decide to join, you can expect to engage in therapy sessions and use the mobile app as part of your treatment. This trial is currently looking for participants, and it offers a chance to try a new approach to improving mental health in a supportive environment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult status (18+ years),
  • a recent suicide attempt or any report of current suicidal ideation,
  • the ability to speak and write English fluently, ownership of and consistent access to an internet-capable smartphone (e.g., an iPhone or Android phone), and
  • Exclusion criteria:
  • - the presence of any factor that impairs an individual\'s ability to provide informed consent and comprehend and effectively participate in the study including: an inability to speak or write English fluently, the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, or the presence of extremely agitated or violent behavior.

About Rutgers, The State University Of New Jersey

Rutgers, The State University of New Jersey, is a prestigious public research university renowned for its commitment to advancing medical science and public health. As a leading clinical trial sponsor, Rutgers leverages its extensive academic resources, cutting-edge facilities, and a diverse team of experts to conduct innovative research that addresses critical health challenges. The university fosters collaboration across disciplines, engaging in partnerships with healthcare institutions and industry leaders to enhance the development of novel therapies and improve patient outcomes. With a strong emphasis on ethical standards and regulatory compliance, Rutgers is dedicated to advancing clinical knowledge while prioritizing participant safety and well-being in all of its research endeavors.

Locations

Piscataway, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

EVAN KLEIMAN, Ph.D.

Principal Investigator

Rutgers, The State University of New Jersey

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported